Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities

article has not abstract

Vyšlo v časopise: Drug Companies Should Be Held More Accountable for Their Human Rights Responsibilities. PLoS Med 7(9): e32767. doi:10.1371/journal.pmed.1000344
Kategorie: Editorial
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1000344

Souhrn

article has not abstract

Zdroje

1. NcayiyanaDJ

2001 Antiretroviral therapy cannot be South Africa's first priority. CMAJ 164 1857 1858

2. Doctors without Borders 2001 South Africa: Big Pharma Backs Down. International Activity Report 2001. Available: http://www.doctorswithoutborders.org/publications/ar/report.cfm?id=1204. Accessed 17 August 2010

3. GruskinS

RaadZ

2010 Are Drug Companies Living Up to Their Human Rights Responsibilities? Moving Toward Assessment. PLoS Med 7 9 e1000310 doi:10.1371/journal.pmed.1000310

4. RitterG

2010 Are Drug Companies Living Up to Their Human Rights Responsibilities? The Merck Perspective. PLoS Med 7 9 e1000343 doi:10.1371/journal.pmed.1000343

5. HuntP

KhoslaR

2010 Are Drug Companies Living Up to Their Human Rights Responsibilities? The Perspective of the United Nations Special Rapporteur. PLoS Med 7 9 e1000330 doi:10.1371/journal.pmed.1000330

6. 2008 Report on accountability and human rights guidelines for pharmaceutical companies in relation to access to medicines. This report (A/63/263) was submitted to the General Assembly on 11 August. Available: http://www.essex.ac.uk/human_rights_centre/research/rth/docs/GA2008.pdf. Accessed 25 August 2010

7. HuntP

5 May 2009 Report on Mission to GlaxoSmithKline. UN Human Rights Council. A/HRC/11/12/Add.2. Available: http://www.essex.ac.uk/human_rights_centre/research/rth/UN%20right%20to%20health%20report%20on%20GSK%20as%20published%20May%202009.pdf. Accessed 25 August 2010

8. MorrisK

2010 Bridging the gap in access to medicines. Lancet Inf Dis 10 514 515

9. Pfizer 2010 Human Rights Statement. Available: http://www.pfizer.com/responsibility/workplace_responsibility/human_rights_statement.jsp. Accessed 25 August 2010

10. Merck 2010 Promoting and Respecting Human Rights: Advancing the Dialogue Toward a Healthier Future. Available: http://www.merck.com/corporate-responsibility/basics/human-rights/approach.html. Accessed 25 August 2010

11. GlaxoSmithKline 2010 Human Rights. Available: http://www.gsk.com/responsibility/human-rights/index.htm. Accessed 25 August 2010

12. Novartis 2010 Human Rights. Available: http://www.corporatecitizenship.novartis.com/people-communities/human-rights.shtml. Accessed 25 August 2010

13. LeisingerKM

2005 The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation. Business Ethics Quarterly 15 577 594

14. GlaxoSmithKline June 2009 Statement in Response to Paul Hunt's Report on GSK (A/HRC/11/12/Add.2) Available: http://www.gsk.com/responsibility/downloads/GlaxoSmithKline-Statement-in-response-to-the-Paul-Hunt-Report-on-GSK.pdf. Accessed 25 August 2010

15. Merck 29 February 2008 Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines, prepared by United Nations Special Rapporteur, Paul Hunt. Response from Merck & Co., Inc. Available: http://www.merck.com/corporate-responsibility/docs/access_developing_response_feb08.pdf. Accessed 25 August 2010

16. [No authors listed] 2009 Right-to-health responsibilities of pharmaceutical companies [editorial]. Lancet 373: 1998. Available: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2809%2961090-4/fulltext. Accessed 25 August 2010

17. PottsH

1 January 2008 Accountability and the Right to the Highest Attainable Standard of Health. Report to Human Rights Centre, University of Essex. Available: http://www.essex.ac.uk/human_rights_centre/research/rth/docs/HRC_Accountability_Mar08.pdf. Accessed 25 August 2010